Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2

Chemistry and Biology

Volumn 18, Issue 1, 2011, Pages 58-66

  Dafik, Laila ^a   Khosla, Chaitan ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYNE; AZIDE; ENZYME INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOXAZOLE DERIVATIVE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ARTICLE; BIOCATALYSIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; GENETIC PROCEDURES; HUMAN; METABOLISM; MOLECULAR IMAGING; STAINING; SYNTHESIS; TISSUE CULTURE TECHNIQUE;

ALKYNES; AZIDES; BIOCATALYSIS; CELL LINE; DRUG DESIGN; ENZYME INHIBITORS; GTP-BINDING PROTEINS; HUMANS; ISOXAZOLES; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; STAINING AND LABELING; TISSUE CULTURE TECHNIQUES; TRANSGLUTAMINASES;

EID: 79251542680     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2010.11.004     Document Type: Article

References (42)

1. N.J. Agard, and C.R. Bertozzi Chemical approaches to perturb, profile, and perceive glycans Acc. Chem. Res. 42 2009 788 797
2. S.S. Akimov, and A.M. Belkin Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin Blood 98 2001 1567 1576
3. M.A. Antonyak, B. Li, A.D. Regan, Q.Y. Feng, S.S. Dusaban, and R.A. Cerione Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion J. Biol. Chem. 284 2009 17914 17925
4. Z. Balklava, E. Verderio, R. Collighan, S. Gross, J. Adams, and M. Griffin Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion J. Biol. Chem. 277 2002 16567 16575
5. A. Case, J. Ni, L.A. Yeh, and R.L. Stein Development of a mechanism-based assay for tissue transglutaminase - results of a high-throughput screen and discovery of inhibitors Anal. Biochem. 338 2005 237 244
6. A.L. Castelhano, R. Billedeau, D.H. Pliura, B.J. Bonaventura, and A. Krantz Synthesis, chemistry, and absolute-configuration of novel transglutaminase inhibitors containing a 3-halo-4,5-dihydroisoxazole Bioorg. Chem. 16 1988 335 340
7. J.W. Chin, S.W. Santoro, A.B. Martin, D.S. King, L. Wang, and P.G. Schultz Addition of p-azido-L-phenylalanine to the genetic code of Escherichia coli J. Am. Chem. Soc. 124 2002 9026 9027 (Pubitemid 34847644)
8. K. Choi, M. Siegel, J.L. Piper, L. Yuan, E. Cho, P. Strnad, B. Omary, K.M. Rich, and C. Khosla Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2 Chem. Biol. 12 2005 469 475
9. A. Deiters, and P.G. Schultz In vivo incorporation of an alkyne into proteins in Escherichia coli Bioorg. Med. Chem. Lett. 15 2005 1521 1524
10. L. Fesus, V. Thomazy, and A. Falus Induction and activation of tissue transglutaminase during programmed cell death FEBS Lett. 224 1987 104 108
11. K.F. Freund, K.P. Doshi, S.L. Gaul, D.A. Claremon, D.C. Remy, J.J. Baldwin, S.M. Pitzenberger, and A.M. Stern Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation Biochemistry 33 1994 10109 10119
12. D. Halim, K. Caron, and J.W. Keillor Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors Bioorg. Med. Chem. Lett. 17 2007 305 308
13. H.C. Hang, E.J. Geutjes, G. Grotenbreg, A.M. Pollington, M.J. Bijlmakers, and H.L. Ploegh Chemical probes for the rapid detection of fatty-acylated proteins in mammalian cells J. Am. Chem. Soc. 129 2007 2744 2745
14. F. Hausch, T. Halttunen, M. Maki, and C. Khosla Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase Chem. Biol. 10 2003 225 231
15. S.E. Iismaa, B.M. Mearns, L. Lorand, and R.M. Graham Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders Physiol. Rev. 89 2009 991 1023
16. J.W. Keillor Tissue transglutaminase inhibition Chem. Biol. 12 2005 410 412
17. S.T. Laughlin, and C.R. Bertozzi In vivo imaging of Caenorhabditis elegans glycans ACS Chem. Biol. 4 2009 1068 1072
18. S.T. Laughlin, J.M. Baskin, S.L. Amacher, and C.R. Bertozzi In vivo imaging of membrane-associated glycans in developing zebrafish Science 320 2008 664 667
19. S. Liu, R.A. Cerione, and J. Clardy Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity Proc. Natl. Acad. Sci. USA 99 2002 2743 2747
20. L. Lorand Crosslinks in blood: transglutaminase and beyond FASEB J. 21 2007 1627 1632
21. L. Lorand, and R.M. Graham Transglutaminases: crosslinking enzymes with pleiotropic functions Nat. Rev. Mol. Cell Biol. 4 2003 140 156
22. H. Nakaoka, D.M. Perez, K.J. Baek, T. Das, A. Husain, K. Misono, M.J. Im, and R.M. Graham Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function Science 264 1994 1593 1596
23. B. Nicholas, P. Smethurst, E. Verderio, R. Jones, and M. Griffin Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity Biochem. J. 371 2003 413 422
24. C. Pardin, S. Gillet, and J.W. Keillor Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase Bioorg. Med. Chem. 14 2006 8379 8385
25. C. Pardin, J.N. Pelletier, W.D. Lubell, and J.W. Keillor Cinnamoyl inhibitors of tissue transglutaminase J. Org. Chem. 73 2008 5766 5775
26. M. Piacentini, F. Autuori, L. Dini, M.G. Farrace, L. Ghibelli, L. Piredda, and L. Fesus Tissue transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation Cell Tissue Res. 263 1991 227 235
27. D.M. Pinkas, P. Strop, A.T. Brunger, and C. Khosla Transglutaminase 2 undergoes a large conformational change upon activation PLoS Biol. 5 2007 e327
28. J.A. Prescher, and C.R. Bertozzi Chemistry in living systems Nat. Chem. Biol. 1 2005 13 21
29. Q. Ruan, and G.V. Johnson Transglutaminase 2 in neurodegenerative disorders Front. Biosci. 12 2007 891 904
30. S. Schaertl, M. Prime, J. Wityak, C. Dominguez, I. Munoz-Sanjuan, R.E. Pacifici, S. Courtney, A. Scheel, and D. Macdonald A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors J. Biomol. Screen. 15 2010 478 487
31. N. Shweke, N. Boulos, C. Jouanneau, S. Vandermeersch, G. Melino, J.C. Dussaule, C. Chatziantoniou, P. Ronco, and J.J. Boffa Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration Am. J. Pathol. 173 2008 631 642
32. M. Siegel, and C. Khosla Transglutaminase 2 inhibitors and their therapeutic role in disease states Pharmacol. Ther. 115 2007 232 245
33. M. Siegel, P. Strnad, R.E. Watts, K.H. Choi, B. Jabri, M.B. Omary, and C. Khosla Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury PLoS ONE 3 2008 e1861
34. U.S. Singh, J.W. Erickson, and R.A. Cerione Identification and biochemical characterization of an 80 kilodalton GTP-binding transglutaminase from rabbit liver nuclei Biochemistry 34 1995 15863 15871
35. E.M. Sletten, and C.R. Bertozzi Bioorthogonal chemistry: fishing for selectivity in a sea of functionality Angew. Chem. Int. Ed. Engl. 48 2009 6974 6998
36. L.M. Sollid, and K.E.A. Lundin Diagnosis and treatment of celiac disease Mucosal Immunol. 2 2009 3 7
37. J. Stamnaes, D.M. Pinkas, B. Fleckenstein, C. Khosla, and L.M. Sollid Redox regulation of transglutaminase 2 activity J. Biol. Chem. 285 2010 25402 25409
38. A. Verma, and K. Mehta Tissue transglutaminase-mediated chemoresistance in cancer cells Drug Resist. Updat. 10 2007 144 151 (Pubitemid 47446401)
39. L. Wang, and P.G. Schultz Expanding the genetic code Angew. Chem. Int. Ed. Engl. 44 2004 34 66 (Pubitemid 40069845)
40. R.E. Watts, M. Siegel, and C. Khosla Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles J. Med. Chem. 49 2006 7493 7501
41. L. Yuan, M. Siegel, K. Choi, C. Khosla, C.R. Miller, E.N. Jackson, D. Piwnica-Worms, and K.M. Rich Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy Oncogene 26 2007 2563 2573
42. E.A. Zemskov, A. Janiak, J. Hang, A. Waghray, and A.M. Belkin The role of tissue transglutaminase in cell-matrix interactions Front. Biosci. 11 2006 1057 1076